CD19 and chronic kidney disease: In conclusion, our results showed that decreased CD19(+)CD5(+) and CD19(+)CD5(−) B lymphocytes were correlated with atherosclerosis and worse clinical outcome, which indicated that B lymphocytes may be involved in pathogenesis of atherosclerosis and associated with prognosis in moderate-to-severe CKD.